According to Arizton’s latest research report, the functional milk market will grow at a CAGR of 6.42% from 2022-2028.
Rise in disposable income and improved living standards leading to the inclusion of fortified food products in the diet. The market is also driven by a growth in the geriatric population, increased malnutrition among hospitalized patients, and the prevalence of communicable and non-communicable chronic diseases. Several health benefits associated with functional milk helped it gain popularity among people suffering from vitamin D deficiency and malnutrition, propelling the growth of the global functional milk market.
The demand for powder-based functional milk was the highest in 2022. Powder form functional milk has a long shelf life, is low-cost, has less wastage, and is easy to carry and store, contributing to its fastest growth during the forecast period. The demand for the powder form will continue to grow during the forecast period. In 2022, APAC dominated the global powder functional milk market revenue share. The growth in the awareness of the benefits of functional milk powder, coupled with its increasing market penetration in other potential regions, such as Latin America, is expected to increase its demand further.
Functional Milk Market Report Scope
|Market Size (2028)||USD 36.63 Billion|
|Market Size (2022)||USD 25.22 Billion|
|Market Segmentation||Form, Age Group, Application, Distribution Channel, and Geography|
|Regions||North America, Europe, APAC, Latin America, and Middle East & Africa|
|Countries Covered||China, Japan, South Korea, Australia, India, Thailand, Indonesia, Philippines, Malaysia, Vietnam, the US, Canada, Germany, France, the UK, Spain, Italy, Russia, Brazil, Mexico, Argentina, Turkey, Saudi Africa, and Saudi Arabia|
Looking for More Information? Download the Free Sample Report Now: https://www.arizton.com/request-sample/3748
China has the largest number of people with diabetes globally, with around 116 million in 2019. By 2045, the number is expected to reach 134 million. As a result, various foreign companies plan to expand their footprint in China, wherein several foreign brands are already present in the country, which include Abbott, Danone, and Nestle.
In 2019, China recorded the lowest birth rate, with only 14.65 million newborns, which declined to 12 million in 2020. As a result, pregnant women are required to ensure nutritious food intake. Advancements in the milk formula and increased investments in R&D are expected to drive the demand for high-quality functional milk during the forecast period.
APAC has one of the highest incidences of pre-term births, with China, India, Pakistan, Bangladesh, and Indonesia accounting for the highest number of pre-term births. Thus, APAC is one of the key markets for pre-term parenteral nutrition supplements, which, in turn, fuels the growth of the global functional milk market. The growth in pre-term births and malnourished children leads to the prescription of enteral feeding to avoid the risk of death. Approximately 13.6% of the total APAC population is 60 years and above, and it is projected to reach about 1.3 billion by 2050. This population growth will lead to the incidence and prevalence of various age-related diseases that will drive the demand for functional milk during the forecast period.
Key Company Profiles
- Lactalis International
- Aroma Milk Products
- Arla Foods amba
- Best Way Ingredients
- Best Health Foods
- Bright Life Care
- Crediton Dairy
- Dairy Farmers of America
- F&N Dairies
- Heritage Foods
- Land O’ Lakes
- MEGMILK SNOW BRAND
- Milligans Food Group
- Mother Dairy Fruit & Vegetable
- Parag Milk Foods
- Stolle Milk Biologics
- Vindija d.d.
Form: Powder and Liquid
Age Group: 14–19, 20–64, 1–13, and 65 & Above
Application: Immunity & Disease Management, Weight Management, Clinical Nutrition, and Others
Distribution Channel: Hypermarkets, Convenience Stores, Online, Grocery Stores, Specialty Stores, and Institutional Sales
Geography: North America, Europe, APAC, Latin America, and Middle East & Africa
Countries Covered: China, Japan, South Korea, Australia, India, Thailand, Indonesia, Philippines, Malaysia, Vietnam, The US, Canada, Germany, France, The UK, Spain, Italy, Russia, Brazil, Mexico, Argentina, Turkey, Saudi Africa, and Saudi Arabia
Our team is always ready to answer your questions and concerns, guide you through the purchasing process, and dive into the research report. To learn more about the medical tent market, request an Analyst Brief from Arizton Advisory & Intelligence; our sales team will assist you in making an informed market decision to achieve market growth. We also provide customization solutions based on your business requirements and assistance with your questions and future goals. Our researchers will prioritize your interests and investigate all possible avenues to increase your business profits.
To Get the Benefit of Our Free Report Customization Service, Send Your Enquiry Here – https://www.arizton.com/customize-report/3748
Why Arizton Research Reports?
- 100% Customer Satisfaction
- 24×7 availability – we are always there when you need us.
- 200+ Fortune 500 Companies trust Arizton’s report.
- 80% of our reports are exclusive and first in the industry.
- 100% more data and analysis.
- 1000+ reports published to date.
Arizton’s Expertise in the Healthcare Industry
Arizton offers syndicate and custom market intelligence & competitive intelligence solutions across MedTech, pharmaceuticals, and life sciences & biotechnology markets within the healthcare industry. Arizton’s healthcare vertical provides unbiased research and evidence-based analysis to support business decisions and comprehensive end-to-end solutions to its customers, covering all dimensions of the healthcare value chain. We track various devices (equipment, implants, and hospital supplies) and drugs (patented, generic, & OTC) across North America, Europe, APAC, Latin America, and the Middle East & Africa regions. The healthcare reports provide historic and forecast data for 20+ key countries worldwide. We track product approvals/launches, M&A activities, and collaboration/partnership activities among pharma/biotech, medical device, and life sciences companies. Our pharmaceutical portfolio tracks 15+ therapy areas with a major focus on immunology, oncology, rare & genetic diseases, dermatology, and metabolic diseases. Our medical devices and life sciences portfolio covers in-vitro diagnostics, healthcare IT, patient monitoring, cardiovascular devices, medical imaging, personal protective equipment, clinical laboratory services, and CMO/CDMO services.
Explore more healthcare reports: https://www.arizton.com/market-reports/category/healthcare-lifesciences
Check More Top-Selling Research Reports:
Arizton Advisory and Intelligence is an innovative and quality-driven firm that offers cutting-edge research solutions to clients worldwide. We excel in providing comprehensive market intelligence reports and advisory and consulting services.
We offer comprehensive market research reports on consumer goods & retail technology, automotive and mobility, smart tech, healthcare, life sciences, industrial machinery, chemicals, materials, I.T. and media, logistics, and packaging. These reports contain detailed industry analysis, market size, share, growth drivers, and trend forecasts.
Arizton comprises a team of exuberant and well-experienced analysts who have mastered generating incisive reports. Our specialist analysts possess exemplary skills in market research. We train our team in advanced research practices, techniques, and ethics to outperform in fabricating impregnable research reports.